Opportunity ID: 328024

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-FD-21-002
Funding Opportunity Title: Renewal-Harmonization of Technical Requirements for Pharmaceuticals for Human Use (U01) Clinical Trials Not Allowed
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Consumer Protection
Food and Nutrition
Health
Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 93.103 — Food and Drug Administration Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Jul 08, 2020
Last Updated Date: Jul 08, 2020
Original Closing Date for Applications: Oct 13, 2020
Current Closing Date for Applications: Oct 13, 2020
Archive Date: Nov 12, 2020
Estimated Total Program Funding: $2,500,000
Award Ceiling: $500,000
Award Floor:

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Eligible Organizations International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)
Additional Information on Eligibility:Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the HHS Grants Policy Statement, are allowed.

Additional Information

Agency Name: Food and Drug Administration
Description:

The Food and Drug Administration announces its intention to consider and accept a renewal application for award to the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). The purpose of this program is to provide support in convening regional pharmaceutical regulatory authorities and pharmaceutical industry associations representing regions and jurisdictions from around the world to achieve greater harmonization of scientific and technical standards for pharmaceuticals. This is to ensure that safe, effective, and high-quality medicines are developed and registered in the most resource-efficient manner, to be available to patients globally. The outcome of this effort will be a series of internationally recognized guidelines for pharmaceutical product registration, adopted by regulators in regions around the world. 

Link to Additional Information: Full Announcement RFA-FD-21-002
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Shashi Malhotra

Grants Management Specialist

Phone 2404027592
Email:shashi.malhotra@fda.hhs.gov

Version History

Version Modification Description Updated Date
Update Jul 08, 2020

DISPLAYING: Synopsis 2

General Information

Document Type: Grants Notice
Funding Opportunity Number: RFA-FD-21-002
Funding Opportunity Title: Renewal-Harmonization of Technical Requirements for Pharmaceuticals for Human Use (U01) Clinical Trials Not Allowed
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Consumer Protection
Food and Nutrition
Health
Science and Technology and other Research and Development
Category Explanation:
Expected Number of Awards: 1
Assistance Listings: 93.103 — Food and Drug Administration Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 2
Posted Date: Jul 08, 2020
Last Updated Date: Jul 08, 2020
Original Closing Date for Applications: Oct 13, 2020
Current Closing Date for Applications: Oct 13, 2020
Archive Date: Nov 12, 2020
Estimated Total Program Funding: $2,500,000
Award Ceiling: $500,000
Award Floor:

Eligibility

Eligible Applicants: Others (see text field entitled “Additional Information on Eligibility” for clarification)
Additional Information on Eligibility: Eligible Organizations International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH)
Additional Information on Eligibility:Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply.Foreign components, as defined in the HHS Grants Policy Statement, are allowed.

Additional Information

Agency Name: Food and Drug Administration
Description:

The Food and Drug Administration announces its intention to consider and accept a renewal application for award to the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). The purpose of this program is to provide support in convening regional pharmaceutical regulatory authorities and pharmaceutical industry associations representing regions and jurisdictions from around the world to achieve greater harmonization of scientific and technical standards for pharmaceuticals. This is to ensure that safe, effective, and high-quality medicines are developed and registered in the most resource-efficient manner, to be available to patients globally. The outcome of this effort will be a series of internationally recognized guidelines for pharmaceutical product registration, adopted by regulators in regions around the world. 

Link to Additional Information: Full Announcement RFA-FD-21-002
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

Shashi Malhotra

Grants Management Specialist

Phone 2404027592
Email:shashi.malhotra@fda.hhs.gov

Related Documents

Packages

Agency Contact Information: Shashi Malhotra
Grants Management Specialist
Phone 2404027592
Email: shashi.malhotra@fda.hhs.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
93.103 RFA-FD-21-002 FORMS F PKG00262475 Jul 13, 2020 Oct 13, 2020 View

Package 1

Mandatory forms

328024 RR_SF424_2_0-2.0.pdf

328024 PHS398_CoverPageSupplement_5_0-5.0.pdf

328024 RR_OtherProjectInfo_1_4-1.4.pdf

328024 PerformanceSite_2_0-2.0.pdf

328024 RR_KeyPersonExpanded_2_0-2.0.pdf

328024 RR_Budget_1_4-1.4.pdf

328024 PHS398_ResearchPlan_4_0-4.0.pdf

328024 PHSHumanSubjectsAndClinicalTrialsInfo_2_0-2.0.pdf

Optional forms

328024 RR_SubawardBudget30_1_4-1.4.pdf

328024 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-10T11:49:56-05:00

Share This Post, Choose Your Platform!

About the Author: